WuXi AppTec Reports Record Results in 2022
2023-03-22
WuXi AppTec Medical Device Testing business has operating entities in China and the United States. The Department provides an integrated testing platform for medical devices which includes biocompatibility test, chemical characterization, toxicological risk assessment, biological evaluation, large animal research, microbial test, etc. The testing platform is composed of the outstanding technical and management team in the world. It has established China Medical Device Testing Center in Suzhou Wuzhong District based on international FDA GLP, OECD GLP, CNAS, ISO13485, A2LA quality management standards, China CMA and AAALAC operation standards. WuXi Clinical has ability to provide clinical studies and product registration services for medical devices from phrase I to IV. WuXi MedKey has rich experience in operating more than 200 medical device clinical trials and working closely with 1000 Chinese hospital clinical trial centers.
2023-03-22
WuXi AppTec Reports Record Results in 2022
2023-03-01
The China Food and Drug International Exchange Center
2023-02-20
WuXi AppTec Plans to Build a New Site in Singapore, Better Serving Global Partners and Advancing Healthcare Innovation